Resazurin Assay

Living, metabolically active cells convert blue, nonfluorescent resazurin into pink, fluorescent resorufin through cellular reducing activity. The resulting color or fluorescence signal provides an indirect readout rather than a direct cell count. Under defined conditions, stronger signal generally indicates greater overall reducing activity, which can reflect differences in viable cell abundance or metabolic state.

Signal intensity can change for reasons other than cell number because compounds or organisms may alter dye reduction independently of viability. Consequently, incubation and measurement conditions must be defined for the experimental system. Optimization helps ensure that differences in color or fluorescence more accurately represent changes in cellular or pathogen-associated activity rather than assay interference.

The readout primarily reflects cellular reducing activity, so it serves as an estimate of viable, metabolically active cells rather than a direct enumeration method. Samples with similar cell numbers may produce different signals if their metabolic states differ. This distinction is important when interpreting proliferation, treatment effects, or infection-related changes.

In immunology and infection research, the assay can support measurements of immune-cell proliferation, pathogen growth, antimicrobial activity, and treatment-related cytotoxicity. Its microplate compatibility allows rapid comparisons among samples, making it useful when investigators need to examine multiple conditions. Interpretation still depends on confirming that the tested compounds or organisms do not independently modify dye reduction.

A typical workflow places the relevant cells or organisms under defined experimental conditions, adds resazurin, and then assesses the resulting color or fluorescence change. The signal is compared across samples to estimate differences in metabolic activity or viability-associated response. Microplate formatting supports rapid parallel analysis, while condition optimization helps preserve meaningful comparisons.

Reduced signal relative to a comparison sample can indicate lower reducing activity associated with antimicrobial action, treatment-related cytotoxicity, or diminished cellular activity. The result should be interpreted in the context of the tested system because an antimicrobial compound or treatment might also affect dye reduction directly. Thus, the assay supports comparative screening rather than standalone proof of cell loss.